tiprankstipranks
Trending News
More News >
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
Advertisement

4D Molecular Therapeutics (FDMT) Ownership - Who Owns 4D Molecular Therapeutics?

Compare
380 Followers

4D Molecular Therapeutics (FDMT) Ownership Overview

12.57%15.06%1.83%9.98%60.57%
12.57% Insiders
1.83% Other Institutional Investors
9.98% ETFs
60.57% Public Companies and
Individual Investors
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail, and individual investors. Approximately 26.86% of the company’s stock is owned by Institutional Investors, 12.57% is owned by Insiders, and 60.57% is owned by Public Companies and Individual Investors.
The ownership structure of 4D Molecular Therapeutics (FDMT) stock is a mix of institutional, retail, and individual investors. Approximately 16.89% of the company’s stock is owned by Institutional Investors, 12.57% is owned by Insiders, and 9.98% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$139148

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,563,211Institution9.85%19,256,750
4,563,211Insider9.85%19,256,750
2,364,295Institution5.10%9,977,325
2,033,575Institution4.39%8,581,687
1,774,707Institution3.83%7,489,264
1,515,682Institution3.27%6,396,178
1,059,153Insider2.29%4,469,626
952,085Institution2.06%4,017,799
511,692Institution1.10%2,159,340
354,806Institution0.77%1,497,281

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,033,575Institution4.39%8,581,687
1,515,682Institution3.27%6,396,178
952,085Institution2.06%4,017,799
511,692Institution1.10%2,159,340
354,806Institution0.77%1,497,281
328,501Institution0.71%1,386,274
276,537Institution0.60%1,166,986
158,842Institution0.34%670,313
155,024Institution0.33%654,201
130,435Institution0.28%550,436

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,537,368Institution3.32%5,703,635
1,028,210Institution2.22%4,339,046
496,207Institution1.07%1,840,928
343,873Institution0.74%1,499,286
253,417Institution0.55%1,069,420
204,393Institution0.44%758,298
157,972Institution0.34%688,758
96,309Institution0.21%357,306
87,064Institution0.19%379,599
60,722Institution0.13%256,247

FAQ

Who Owns 4D Molecular Therapeutics (FDMT)?
According to the latest TipRanks data, approximately 1.83% of the company's stock is held by institutional investors, 12.57% is held by insiders, and 60.57% is held by retail investors.
    What percentage of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.83% of 4D Molecular Therapeutics (FDMT) stock is held by institutional investors.
      What percentage of 4D Molecular Therapeutics (FDMT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 60.57% of 4D Molecular Therapeutics (FDMT) stock is held by retail investors.
        Who owns the most shares of 4D Molecular Therapeutics (FDMT)?
        Peter Kolchinsky owns the most shares of 4D Molecular Therapeutics (FDMT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis